Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

Patent for wound healing technology patent awarded to BioSpecifics and Tufts

Aug. 5, 1999

Oxis receives U.S. patent for lipid-soluble antioxidants for skin protection

Aug. 4, 1999

Integra LifeSciences's dural graft matrix granted 510(k) clearance by FDA

Aug. 3, 1999

Connetics seeks FDA approval of scalp dermatoses treatment

July 30, 1999

Adolor and SmithKline Beecham sign licensing agreement for ADL-2-1294

July 29, 1999

Patient enrollment completed in Anogesic phase III trial

July 27, 1999

IDE granted to Gliatech for ADCON-A

July 22, 1999

Nonsteroidal Rx for atopic dermatitis enters late-stage clinical trials in U.S.

July 13, 1999

Positive results from phase II psoriasis study of hu1124 presented at dermatology meeting

July 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...